BR0112362A - Processo para a preparação de octanoil amidas substituìdas - Google Patents

Processo para a preparação de octanoil amidas substituìdas

Info

Publication number
BR0112362A
BR0112362A BR0112362-9A BR0112362A BR0112362A BR 0112362 A BR0112362 A BR 0112362A BR 0112362 A BR0112362 A BR 0112362A BR 0112362 A BR0112362 A BR 0112362A
Authority
BR
Brazil
Prior art keywords
preparation
group
amides
replaced
formula
Prior art date
Application number
BR0112362-9A
Other languages
English (en)
Other versions
BR0112362B1 (pt
Inventor
Peter Herold
Stefan Stutz
Felix Spindler
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Publication of BR0112362A publication Critical patent/BR0112362A/pt
Publication of BR0112362B1 publication Critical patent/BR0112362B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Abstract

"PROCESSO PARA A PREPARAçãO DE OCTANOIL AMIDAS SUBSTITUìDAS". A presente invenção refere-se a compostos de fórmula (II) que são simultaneamente halogenados na posição 5 e hidroxilados na posição 4 sob lactonização, a halolactona é convertida em uma hidroxilactona e em seguida o grupo hidróxi em um grupo de partida, o grupo de partida é substituído com azida, a lactona amidada e em seguida a azida convertida em um grupo amina, a fim de obter compostos de fórmula (1).
BRPI0112362-9B1A 2000-07-05 2001-06-26 Processo para a preparação de octanoil amidas substituídas e compostos intermediários BR0112362B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH13292000 2000-07-05
CH24502000 2000-12-15
PCT/CH2001/000399 WO2002002508A1 (en) 2000-07-05 2001-06-26 Process for the preparation of substituted octanoyl amides

Publications (2)

Publication Number Publication Date
BR0112362A true BR0112362A (pt) 2003-05-13
BR0112362B1 BR0112362B1 (pt) 2013-12-31

Family

ID=25738979

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0112362-9B1A BR0112362B1 (pt) 2000-07-05 2001-06-26 Processo para a preparação de octanoil amidas substituídas e compostos intermediários

Country Status (24)

Country Link
US (1) US6730798B2 (pt)
EP (1) EP1296935B1 (pt)
JP (1) JP4900755B2 (pt)
KR (1) KR100690471B1 (pt)
CN (1) CN100482636C (pt)
AR (1) AR029564A1 (pt)
AT (1) ATE426592T1 (pt)
AU (2) AU2001273763B2 (pt)
BR (1) BR0112362B1 (pt)
CA (1) CA2414847C (pt)
CY (1) CY1109110T1 (pt)
DE (1) DE60138099D1 (pt)
DK (1) DK1296935T3 (pt)
ES (1) ES2322547T3 (pt)
HK (1) HK1093201A1 (pt)
HU (1) HU228526B1 (pt)
IL (4) IL153717A0 (pt)
MX (1) MXPA02012628A (pt)
NO (1) NO328105B1 (pt)
NZ (1) NZ523088A (pt)
PL (1) PL212898B1 (pt)
PT (1) PT1296935E (pt)
TW (1) TWI289551B (pt)
WO (1) WO2002002508A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060154926A1 (en) * 2002-06-11 2006-07-13 Elan Pharmaceuticals, Inc. Methods of treating alzheimer's disease using aryl alkanoic acid amides
GB0419361D0 (en) 2004-08-31 2004-10-06 Novartis Ag Organic compounds
GB0511686D0 (en) 2005-06-08 2005-07-13 Novartis Ag Organic compounds
PT1904469E (pt) 2005-07-11 2012-01-06 Novartis Ag Novos derivados de pirocatequina
GB0519764D0 (en) 2005-09-28 2005-11-09 Novartis Ag Organic compounds
GB2431645A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
GB2431649A (en) * 2005-10-25 2007-05-02 Novartis Ag Alternative synthesis of aryl-octanoyl amide compounds
DE102005052195A1 (de) 2005-10-28 2007-05-03 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von chiralen Octensäurederivaten
GB0605688D0 (en) 2006-03-21 2006-05-03 Novartis Ag Organic compounds
RU2466982C2 (ru) * 2006-11-07 2012-11-20 Новартис Аг Кристаллические формы гемифумарата алискирена
CA2665073A1 (en) * 2006-11-09 2008-05-15 Novartis Ag Salt of aliskiren with orotic acid
EP1958666A1 (en) 2007-02-13 2008-08-20 Speedel Experimenta AG Heterocyclic-substituted alkanamides as therapeutic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
US20120029083A1 (en) 2007-11-13 2012-02-02 Teva Pharmaceutical Industries, Ltd. Polymorphic forms of aliskiren hemifumarate and process for preparation thereof
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
CA2724746A1 (en) * 2008-05-23 2009-11-26 Teva Pharmaceuticals Industries Ltd. Aliskiren monofumarate and processes for preparation thereof
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
CA2724152A1 (en) * 2009-02-05 2010-08-12 Teva Pharmaceutical Industries Ltd. Solid state forms of aliskiren compounds
EP2393489B1 (en) 2009-02-05 2014-10-08 Krka, tovarna zdravil, d.d., Novo mesto Moisture-activated granulation process
US20120220663A1 (en) 2009-09-03 2012-08-30 Teva Pharmaceuticals Usa, Inc. Solid forms of aliskiren hemifumarate and processes for preparation thereof
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
US20110113995A1 (en) * 2009-11-13 2011-05-19 Lindsay Corporation Method and apparatus for planting and irrigation
WO2011148392A1 (en) * 2010-05-28 2011-12-01 Msn Laboratories Limited Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof
EP2630118B1 (en) * 2010-10-19 2014-11-05 Mylan Laboratories Limited Synthesis of aliskiren
ITMI20110893A1 (it) * 2011-05-19 2012-11-20 Chemelectiva S R L Processi ed intermedi per la sintesi di aliskiren
EP2551260A1 (en) 2011-07-28 2013-01-30 Chemo Ibérica, S.A. Chemical process for opening ring compounds
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
WO2013118138A1 (en) 2011-12-13 2013-08-15 Laboratories Ltd Mylan Novel process for the preparation of renin inhibitors
EP2814806B1 (en) 2012-02-17 2016-05-25 Mylan Laboratories Ltd. An improved process for the preparation of aliskiren
WO2013124868A2 (en) 2012-02-21 2013-08-29 Mylan Laboratories Limited Solid form of aliskiren intermediate
WO2013144979A1 (en) 2012-03-28 2013-10-03 Maylan Laboratories Ltd Process for the preparation of aliskiren
WO2013171767A1 (en) 2012-05-18 2013-11-21 Mylan Laboratories Limited An improved process for the preparation of aliskiren
CN106220528B (zh) * 2014-02-28 2018-05-08 华润双鹤药业股份有限公司 阿利吉仑的4-位差向异构体、其制备方法及用途
CN106146339B (zh) * 2015-04-23 2018-02-23 华润双鹤药业股份有限公司 阿利吉仑的5‑位差向异构体、其制备方法及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492799A (en) * 1979-07-02 1985-01-08 Union Carbide Corporation Halo-4-alkenoic acids and their use as pesticidal intermediates
FR2666757B1 (fr) * 1990-09-14 1992-12-18 Usinor Sacilor Virole pour cylindre de coulee continue des metaux, notamment de l'acier, entre cylindres ou sur un cylindre.
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
EP0773844B1 (de) * 1994-07-18 1998-12-09 Siemens Aktiengesellschaft Giesswalzen-verschleissschutzschicht
AU7418198A (en) * 1997-05-23 1998-12-11 Voest-Alpine Industrieanlagenbau Gmbh Casting cylinder for thin-band continuous casting installation
PT1200384E (pt) 1999-07-29 2004-09-30 Speedel Pharma Ag Acidos 2-alquil-5-halogeneo-pent-4-enocarboxilicos e sua producao

Also Published As

Publication number Publication date
HUP0301463A3 (en) 2008-03-28
CY1109110T1 (el) 2014-07-02
EP1296935B1 (en) 2009-03-25
IL187795A0 (en) 2008-03-20
AR029564A1 (es) 2003-07-02
JP2004502667A (ja) 2004-01-29
ATE426592T1 (de) 2009-04-15
IL187796A (en) 2009-05-04
AU2001273763B2 (en) 2006-07-13
NO20030012D0 (no) 2003-01-02
IL187796A0 (en) 2008-03-20
US6730798B2 (en) 2004-05-04
DK1296935T3 (da) 2009-06-22
IL153717A (en) 2008-11-03
CA2414847A1 (en) 2002-01-10
IL187795A (en) 2009-05-04
PL358887A1 (en) 2004-08-23
HUP0301463A2 (hu) 2003-09-29
PL212898B1 (pl) 2012-12-31
NO328105B1 (no) 2009-12-07
EP1296935A1 (en) 2003-04-02
CA2414847C (en) 2009-06-16
ES2322547T3 (es) 2009-06-23
US20030149303A1 (en) 2003-08-07
NO20030012L (no) 2003-03-03
BR0112362B1 (pt) 2013-12-31
JP4900755B2 (ja) 2012-03-21
IL153717A0 (en) 2003-07-06
HU228526B1 (hu) 2013-03-28
HK1093201A1 (en) 2007-02-23
KR20030017543A (ko) 2003-03-03
CN1440381A (zh) 2003-09-03
PT1296935E (pt) 2009-05-15
KR100690471B1 (ko) 2007-03-09
AU7376301A (en) 2002-01-14
DE60138099D1 (de) 2009-05-07
TWI289551B (en) 2007-11-11
NZ523088A (en) 2004-06-25
CN100482636C (zh) 2009-04-29
MXPA02012628A (es) 2004-09-10
WO2002002508A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
BR0112362A (pt) Processo para a preparação de octanoil amidas substituìdas
MA26962A1 (fr) Derives de benzodiazepine tels que gaba en tant que modulateurs de reception.
BR0206955A (pt) Ligantes de receptores de canabinóides
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
TR200001199T2 (tr) Oksazolidinonların üretimi için işlem
PT931083E (pt) Processo para a producao de compostos de ecteinascidina
DE60137364D1 (de) Kristalline formen von atorvastatin
BR9815464A (pt) Polìmero, processo de preparação de polìmeros, utilização de um polìmero, composição, associação de pelo menos um polìmero com pelo menos um composto e composição cosmética
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
PT687251E (pt) Derivados de 1,3-di-hidro-indol-2-ona, substituidos na posicao 3 por um grupo azoto , como agonistas ou antagonistas da vasopressina e/ou ocitocina
PL357553A1 (en) Novel 1,3-dihydro-2h
SV2002000462A (es) 5-cloro-3-(4-metansulfonilfenilo)-6'-metil-/2,3'/bipiridinilo en forma cristalina pura y proceso para la sintesis ref. b.12483/lg
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
ES2093099T3 (es) Preparacion de piperidinas sustituidas.
BR0210266A (pt) Composição farmacêutica que compreende um inibidor de lìpases, processo para preparar essa composição, conjunto para o tratamento de obesidade, utilização da composição, processo de tratamento de obesidade e inibidor de lìpases
KR950017992A (ko) 알프조신 염산염의 2수화물
BR0208999A (pt) Processo para a preparação de ácido de cefpodoxima
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
BRPI0409016A (pt) processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
BR0115872A (pt) Processo e derivados de éster úteis para a preparação de cefalosporinas
BRPI9807312B8 (pt) derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados
BR0308890A (pt) Composto
BR0114709A (pt) Métodos para a preparação de bifenil isoxazol sulfonamidas
BR9902525A (pt) Processo para compostos de ácido pirrolidinil-hidroxâmico

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 31/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B25A Requested transfer of rights approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.